Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eline Magois is active.

Publication


Featured researches published by Eline Magois.


Clinical Infectious Diseases | 2006

Apparent Absence of Pneumocystis jirovecii in Healthy Subjects

Gilles Nevez; Eline Magois; Hyacinthe Duwat; Valérie Gouilleux; Vincent Jounieaux; Anne Totet

We prospectively investigated 30 healthy subjects with normal CD4+ T cell counts in blood and normal findings of spirometry and chest radiography for the presence of Pneumocystis jirovecii, by performing polymerase chain reaction on sputum specimens. Fifty patients with chronic obstructive pulmonary disease were investigated at the same time in the same manner; this group was used as controls for the diagnosis of pulmonary colonization with P. jirovecii. None of the healthy subjects had positive test results, whereas the fungus was detected in 8 patients with chronic obstructive pulmonary disease. The results suggest that in our region (Amiens, France), P. jirovecii is apparently uncommon in healthy subjects and that this population, therefore, plays a minor role in circulation of the fungus within human communities.


Histopathology | 2014

Prognostic relevance of histological variants in nonspecific interstitial pneumonia.

Marianne Kambouchner; Pierre Levy; Andrew G. Nicholson; Kirsten Schubel; Eline Magois; S. Feuillet; Dominique Valeyre; Jean-François Bernaudin; Hilario Nunes

Although histological non‐specific interstitial pneumonia (NSIP) is concisely defined, overlap with other patterns is described. While most frequently idiopathic, NSIP is seen in various clinical contexts such as connective tissue diseases (CTDs) and chronic hypersensitivity pneumonitis (cHP). This study was designed to determine if NSIP could be separated into subgroups based on minor histological features and to correlate these subgroups with clinical associations and survival.


Journal of Eukaryotic Microbiology | 2003

Multilocus Genotyping of Pneumocystis jirovecii in Patients Developing Diverse Forms of Parasitism: Implication for a Wide Human Reservoir for the Fungus

Anne Totet; Sophie Latouche; Hyacinthe Duwat; Eline Magois; Philippe Lacube; Jean-Claude Pautard; Jean-Luc Schmit; Vincent Jounieaux; Patricia Roux; Christian Raccurt; Gilles Nevez

ABSTRACT. Pneumocystis jirovecii ITS and DHPS genotypes were identified in 3 patient groups developing diverse forms of P. jirovecii infections: 13 patients with Pneumocystis pneumonia, 8 patients merely colonized by the fungus, and 19 immunocompetent infants with bronchiolitis developing mild P. jirovecii infection. Common P. jirovecii genotypes were found in the 3 patient groups, suggesting that common sources of P. jirovecii were involved in the fungus acquisition, and that transmission cycles of P. jirovecii infections in these patient groups are not independent. Parasitized patients, whatever the form of parasitism they present, may he part of a common reservoir for P. jirovecii.


European Respiratory Journal | 2018

Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation

Aurélien Justet; Gabriel Thabut; Effrosyni D. Manali; Maria Molina Molina; Caroline Kannengiesser; Jacques Cadranel; Vincent Cottin; Anne Gondouin; Hilario Nunes; Eline Magois; Cécile Tromeur; Grégoire Prévot; Spyros Papiris; S. Marchand-Adam; Anne Sophie Gamez; Martine Reynaud-Gaubert; Lidwine Wemeau; Bruno Crestani; Raphael Borie

The most frequent mutations in familial pulmonary fibrosis (FPF) involve genes of the telomerase complex such as TERT, TERC, RTEL1, PARN or DKC1 [1]. Mutations within TERT and TERC are found in 15–20% of FPF and are associated with blood, liver and skin disorders. Idiopathic pulmonary fibrosis (IPF) is the most frequent multidisciplinary diagnosis in TERT and TERC mutation carriers [1, 2]. Treatment of IPF in patients who carry a TERT or TERC mutation has not been previously defined. Recently, danazol, a synthetic androgen, was shown to increase telomere length, and seemed to stabilise forced vital capacity (FVC) and diffusing capacity of the lung for carbon monoxide (DLCO) in telomerase complex mutation carriers [3]. Pirfenidone has been shown to reduce FVC decline and to improve progression-free survival in IPF [4, 5]; however, pirfenidone has not been specifically evaluated in telomerase complex mutation carriers. The aim of this multicentre retrospective study was to evaluate the safety and efficacy of pirfenidone in patient carriers of TERT/TERC mutations. In this retrospective study, a beneficial effect of pirfenidone on lung function decline could not be demonstrated in patients carrying TERT/TERC mutation http://ow.ly/VYpJ30i5wSr


Journal of Pulmonary and Respiratory Medicine | 2015

Pulmonary Embolism in Patients Hospitalized for Exacerbated COPD andWheezing

Claire Poulet; Marine Woimant; Estelle Hoguet; Eline Magois; Marianne Auquier; Marie-Antoinette Sevestre-Pietri; Damien Basille; Claire Andrejak; Vincent Jounieaux

Background: Prevalence of pulmonary embolism (PE), a potentially lethal disease which can mimic exacerbation of chronic obstructive pulmonary disease (COPD) remains controversial. Objective of the study: The main objective was to determine prevalence of PE in COPD patients hospitalized for exacerbation with wheezing at presentation. The secondary objectives were to compare the prevalence of PE according to COPD GOLD stages and to identify predictive factors for PE in COPD population. Methods: We conducted a prospective study in all consecutive patients hospitalized for COPD exacerbation of unknown origin with wheezing at presentation. Patients underwent a spiral computed tomography (CT) angiography and venous lower-limb Doppler ultrasonography. Results: 87 patients (71 males, mean age: 67.1 ± 11.2 years, 32 GOLD stage-III and 24 GOLD stage-IV patients) had an interpretable spiral CT angiography which showed eight right and five bilateral unsuspected PEs. Deep vein thrombosis was found in nine patients (associated with PE in three). The prevalence of PE and venous thromboembolism (VTE) occurred respectively in 14.9% and 21.8%. No statistical differences were found between risk factors, Geneva score or clinical signs in patients with and without PE. PE was not related to the severity of COPD. Conclusion: There was a 14.9% prevalence of unexpected PE in patients with exacerbated COPD and wheezing at presentation. VTE events were not correlated with the severity of COPD.


Revue Des Maladies Respiratoires | 2009

Une dyspnée fébrile

Marjolaine Gosset; C. Andrejak; Eline Magois; P. Aubry; I. Mayeux; B. Toublanc; N. Ammenouche; D. Carmi; Christophe Renard; Vincent Jounieaux

Monsieur I., âgé de 66 ans s’est présenté aux urgences pour dyspnée et hyperthermie. En dehors d’un éthylisme chronique (80 grammes par jour) et d’un tabagisme estimé à 40 paquets-années, Monsieur I. n’a aucun antécédent médical ou chirurgical. Sur le plan professionnel, il a été cheminot avec exposition probable à l’amiante puis conducteur de tracteur élévateur. Son traitement à domicile ne comportait que du méprobamate. Depuis une semaine, il était fébrile. Il a présenté un épisode de vomissement et de diarrhée cinq jours avant son hospitalisation et une toux avec des expectorations purulentes depuis 3 jours. À l’arrivée aux urgences, la température était de 38.8° avec une hémodynamique conservée et une conscience normale (score de Glasgow à 15). Sur le plan clinique, le patient ne présentait qu’une toux productive sans hémoptysie ou douleur thoracique associées. L’auscultation pulmonaire retrouvait un murmure vésiculaire bilatéral et symétrique avec des râles crépitants bibasaux. Les bruits du cœur étaient réguliers sans souffle audible et l’abdomen souple et non douloureux. Un mauvais état bucco-dentaire était constaté. Le reste de l’examen était sans particularité. Le bilan biologique mettait en évidence un syndrome inflammatoire (12 000 leucocytes/mm _ dont 88 % de polynucléaires neutrophiles (PNN), une CRP à 120 mg/l) et une hypoxémie (gazométrie artérielle en air ambiant : PaO 2 = 59 mmHg, PaCO 2 = 35 mmHg, pH = 7,45). L’ionogramme sanguin, la fonction rénale et les enzymes cardiaques étaient normaux. La radiographie thoracique est présentée figure 1 . Sur le plan bactériologique, l’antigénurie pneumocoque s’avérait positive (antigénurie légionnelle négative). L’examen cytobactériologique des crachats (prélèvement de mauvaise qualité avec plus de 25 cellules épithéliales par champ et plus de 25 PNN par champ) ne retrouvait pas de germe à l’examen direct. Les hémocultures ont été prélevées. L’examen cytobactériologique des urines n’objectivait pas de leucocyte ni de germe à l’examen direct.


Revue Des Maladies Respiratoires | 2005

Tumor or not tumor ? c’est la question

Eline Magois; J.-C. Glérant; B. Toublanc; I. Mayeux; D. Mispelaere; H. Sevestre; Vincent Jounieaux

Madame L., âgée de 70 ans, est hospitalisée dans le service de Neurologie en septembre 2003 pour trouble de la conscience. Ses antécédents sont marqués par un épisode d’hémoptysie en 1982 dont le bilan étiologique s’était révélé négatif (radiographie thoracique, fibroscopie bronchique et artériographie bronchique), une cirrhose éthylique diagnostiquée sur ponction biopsique hépatique en 1987. À son admission, il n’y a pas de notion d’alcoolisation aigue, de sevrage alcoolique récent ou de prise de toxiques. Elle ne prend pas de traitement à domicile. Le scanner cérébral sans injection est normal. La radiographie thoracique objective des opacités hilaires bilatérales d’allure tumorale (fig. 1). L’évolution clinique est marquée par l’apparition d’un encombrement bronchique d’aggravation progressive. Au troisième jour de son hospitalisation, la gazométrie artérielle retrouve une acidose respiratoire (pH : 7,18, pCO2 : 13,7 kPa, pO2 : 6,4 kPa en air ambiant) et la radiographie thoracique une atélectasie pulmonaire gauche. Devant des troubles de la conscience, la patiente est intubée et transférée dans le service de Réanimation pneumologique. À son arrivée, les paramètres hémodynamiques sont stables, la patiente est apyrétique. L’auscultation cardiaque retrouve des bruits du cœur irréguliers, il n’existe pas de signe d’insuffisance cardiaque droite ou gauche. L’auscultation pulmonaire retrouve des ronchus diffus. Il n’existe pas de signes de décompensation œdemato-ascitique. Le bilan biologique est normal. La gazométrie artérielle se normalise sous ventilation. L’électrocardiogramme met en évidence une arythmie complète par fibrillation auriculaire (ACFA).


Lung Cancer | 2008

Multimodal treatment of thymic carcinoma: Report of nine cases

Eline Magois; J. Guigay; Patrick Saint Blancard; J. Margery; Bernard Milleron; L'Her P; Vincent Jounieaux


Microbiology | 2004

Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection

Anne Totet; Hyacinthe Duwat; Eline Magois; Vincent Jounieaux; Patricia Roux; Christian Raccurt; Gilles Nevez


European Respiratory Journal | 2016

Safety and efficacy of pirfenidone in patients with lung fibrosis and TERT mutation

Aurélien Justet; Raphael Borie; Hilario Nunes; Vincent Cottin; Sylvain Marchand Adam; Jacques Cadranel; Emmanuel Bergot; Lidwine Wemeau-Stervineau; Jean Marc Naccache; Eline Magois; I. Frachon; Anne Gondouin; Anas Medhaoui; J.-F. Cordier; Dominique Valeyre; Bernard Grandchamp; Caroline Kanengiesser; Bruno Crestani

Collaboration


Dive into the Eline Magois's collaboration.

Top Co-Authors

Avatar

Vincent Jounieaux

Cliniques Universitaires Saint-Luc

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anne Totet

University of Picardie Jules Verne

View shared research outputs
Top Co-Authors

Avatar

Claire Andrejak

University of Picardie Jules Verne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hyacinthe Duwat

University of Picardie Jules Verne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge